Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Konstantinos Venetis
Observed names:
K. Venetis,
VENETIS, KONSTANTINOS,
Venetis, Konstantinos
Institution:
European Institute of Oncology
Observed institutions:
University of Milan,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
European Institute of Oncology
ORCID:
0000-0002-0163-879X
Observed ORCID:
0000-0002-0163-879X
OpenAlex ID:
A5003154349
Works
138
Awards
1
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
2020
·
Nicola Fusco
, Elham Sajjadi
, et al.
·
Genes
·
185
PDF
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
2022
·
Konstantinos Venetis
, Edoardo Crimini
, et al.
·
Frontiers in Molecular Biosciences
·
161
PDF
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
2023
·
Mariia Ivanova
, Francesca Maria Porta
, et al.
·
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
·
128
PDF
Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management
2021
·
Konstantinos Venetis
, Roberto Piciotti
, et al.
·
Cells
·
114
PDF
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial
2025
·
Giulia Marvaso
, Giulia Corrao
, et al.
·
The Lancet Oncology
·
111
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
2022
·
Chiara Corti
, Konstantinos Venetis
, et al.
·
Expert Opinion on Investigational Drugs
·
92
PDF
Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study
2020
·
Marco Invernizzi
, Alessandro de Sire
, et al.
·
Frontiers in Oncology
·
87
PDF
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing
2023
·
Konstantinos Venetis
, Francesco Pepe
, et al.
·
Cancer Treatment Reviews
·
75
International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors
2025
·
Nicola Fusco
, Konstantinos Venetis
, et al.
·
The Journal of Liquid Biopsy
·
74
PDF
Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
2019
·
Fabio Pagni
, Elena Guerini-Rocco
, et al.
·
International Journal of Molecular Sciences
·
64
PDF
Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization
2021
·
Elham Sajjadi
, Konstantinos Venetis
, et al.
·
Cancer Cell International
·
54
PDF
Characterization of the immune microenvironment in malignant pleural mesothelioma reveals prognostic subgroups of patients
2020
·
Nicola Fusco
, Valentina Vaira
, et al.
·
Lung Cancer
·
51
Cancer in a drop: Advances in liquid biopsy in 2024
2025
·
Roberto Borea
, Erick F. Saldanha
, et al.
·
Critical Reviews in Oncology/Hematology
·
46
Improving HER2 testing reproducibility in HER2-low breast cancer
2022
·
Elham Sajjadi
, Konstantinos Venetis
, et al.
·
Cancer Drug Resistance
·
45
PDF
Liquid biopsy: Cell-free DNA based analysis in breast cancer
2023
·
Konstantinos Venetis
, Giulia Cursano
, et al.
·
The Journal of Liquid Biopsy
·
44
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
2023
·
Elham Sajjadi
, Elena Guerini-Rocco
, et al.
·
Frontiers in Molecular Biosciences
·
44
PDF
Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?
2020
·
Elham Sajjadi
, Konstantinos Venetis
, et al.
·
ecancermedicalscience
·
43
PDF
Cellular immunotherapy in breast cancer: The quest for consistent biomarkers
2020
·
Konstantinos Venetis
, Marco Invernizzi
, et al.
·
Cancer Treatment Reviews
·
43
PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer
2020
·
Gianluca Lopez
, Marianna Noale
, et al.
·
International Journal of Molecular Sciences
·
42
PDF
Immunotherapy in Breast Cancer Patients: A Focus on the Use of the Currently Available Biomarkers in Oncology
2021
·
Carmen Criscitiello
, Elena Guerini-Rocco
, et al.
·
Anti-Cancer Agents in Medicinal Chemistry
·
40
PDF
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
2023
·
Mariia Ivanova
, Francesca Maria Porta
, et al.
·
Genes
·
38
PDF
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study
2023
·
Francesco Pepe
, Elena Guerini-Rocco
, et al.
·
Journal of Clinical Pathology
·
37
PDF
HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes
2022
·
Mariia Ivanova
, Konstantinos Venetis
, et al.
·
Life
·
37
PDF
Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials
2022
·
Alessandro de Sire
, Lorenzo Lippi
, et al.
·
Frontiers in Oncology
·
37
PDF
Low-risk triple-negative breast cancers: Clinico-pathological and molecular features
2022
·
Nicola Fusco
, Elham Sajjadi
, et al.
·
Critical Reviews in Oncology/Hematology
·
36
Show more works
View as search
Works count:
138
Citation count:
2,753
H-index:
31
I10-index:
63
Year
Topic
Type